Inspire Medical Systems Inc (INSP) - Net Assets
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has net assets worth $792.34 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($911.38 Million) and total liabilities ($119.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Inspire Medical Systems Inc to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $792.34 Million |
| % of Total Assets | 86.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | 241.05% |
| 10-Year Change | N/A |
| Growth Volatility | 3611.81 |
Inspire Medical Systems Inc - Net Assets Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Inspire Medical Systems Inc to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual net assets of Inspire Medical Systems Inc from 2016 to 2025. For live valuation and market cap data, see Inspire Medical Systems Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $781.16 Million | +13.26% |
| 2024-12-31 | $689.70 Million | +20.47% |
| 2023-12-31 | $572.51 Million | +15.42% |
| 2022-12-31 | $496.01 Million | +116.55% |
| 2021-12-31 | $229.05 Million | -0.30% |
| 2020-12-31 | $229.75 Million | +64.30% |
| 2019-12-31 | $139.84 Million | -14.73% |
| 2018-12-31 | $164.00 Million | +10951.15% |
| 2017-12-31 | $1.48 Million | +122.46% |
| 2016-12-31 | $-6.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Inspire Medical Systems Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3891800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $29.00K | 0.00% |
| Other Comprehensive Income | $464.00K | 0.06% |
| Other Components | $927.16 Million | 118.69% |
| Total Equity | $781.16 Million | 100.00% |
Inspire Medical Systems Inc Competitors by Market Cap
The table below lists competitors of Inspire Medical Systems Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangxi Hungpai New Material Co Ltd
SHG:605366
|
$1.22 Billion |
|
Ouster, Inc. Common Stock
NASDAQ:OUST
|
$1.22 Billion |
|
First Tractor Co Ltd
SHG:601038
|
$1.22 Billion |
|
Huludao Zinc Industry Co Ltd
SHE:000751
|
$1.22 Billion |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
$1.22 Billion |
|
Shenzhen Baoming Technology Co
SHE:002992
|
$1.22 Billion |
|
Gold.com, Inc.
NYSE:GOLD
|
$1.21 Billion |
|
tonies SE
F:TNIE
|
$1.21 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Inspire Medical Systems Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 689,695,000 to 781,160,000, a change of 91,465,000 (13.3%).
- Net income of 145,422,000 contributed positively to equity growth.
- Share repurchases of 175,019,000 reduced equity.
- Other comprehensive income decreased equity by 72,000.
- Other factors increased equity by 121,134,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $145.42 Million | +18.62% |
| Share Repurchases | $175.02 Million | -22.41% |
| Other Comprehensive Income | $-72.00K | -0.01% |
| Other Changes | $121.13 Million | +15.51% |
| Total Change | $- | 13.26% |
Book Value vs Market Value Analysis
This analysis compares Inspire Medical Systems Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.62x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-0.53 | $42.61 | x |
| 2017-12-31 | $0.11 | $42.61 | x |
| 2018-12-31 | $11.25 | $42.61 | x |
| 2019-12-31 | $5.87 | $42.61 | x |
| 2020-12-31 | $8.81 | $42.61 | x |
| 2021-12-31 | $8.40 | $42.61 | x |
| 2022-12-31 | $17.67 | $42.61 | x |
| 2023-12-31 | $19.54 | $42.61 | x |
| 2024-12-31 | $22.58 | $42.61 | x |
| 2025-12-31 | $26.25 | $42.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Inspire Medical Systems Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.62%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.95%
- • Asset Turnover: 1.01x
- • Equity Multiplier: 1.16x
- Recent ROE (18.62%) is above the historical average (-124.67%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -112.79% | 1.25x | 0.00x | $-17.87 Million |
| 2017 | -1179.99% | -61.30% | 1.14x | 16.91x | $-17.66 Million |
| 2018 | -13.31% | -43.14% | 0.25x | 1.22x | $-38.23 Million |
| 2019 | -23.77% | -40.52% | 0.45x | 1.30x | $-47.23 Million |
| 2020 | -24.90% | -49.58% | 0.41x | 1.22x | $-80.18 Million |
| 2021 | -18.36% | -18.01% | 0.79x | 1.29x | $-64.95 Million |
| 2022 | -9.05% | -11.00% | 0.72x | 1.14x | $-94.48 Million |
| 2023 | -3.69% | -3.39% | 0.92x | 1.18x | $-78.40 Million |
| 2024 | 7.76% | 6.67% | 0.99x | 1.17x | $-15.46 Million |
| 2025 | 18.62% | 15.95% | 1.01x | 1.16x | $67.31 Million |
Industry Comparison
This section compares Inspire Medical Systems Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $339,406,921
- Average return on equity (ROE) among peers: -53.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Inspire Medical Systems Inc (INSP) | $792.34 Million | 0.00% | 0.15x | $1.22 Billion |
| Abbott Laboratories (ABT) | $2.09 Billion | 30.22% | 1.09x | $153.73 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $15.10 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $2.49 Million |
| Acutus Medical Inc (AFIB) | $-225.81 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $1.58 Billion | 5.73% | 1.84x | $1.31 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $456.18K | -277.12% | 2.12x | $6.80 Million |
| Allurion Technologies, Inc. (ALUR) | $-34.28 Million | 0.00% | 0.00x | $13.77 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $80.23 Million | 5.55% | 0.17x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $6.39 Million | 7.83% | 0.24x | $172.10 Million |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more